Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure

Abstract Aims As NEP degrades many substrates, the specific therapeutic mechanism of NEP inhibition with angiotensin receptor neprilysin inhibitor (ARNi) in heart failure with reduced ejection fraction (HFrEF) is not entirely evident. The aim of this study was to investigate the response of two subs...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Henrike Arfsten, Georg Goliasch, Philipp E. Bartko, Suriya Prausmüller, Georg Spinka, Anna Cho, Johannes Novak, Julia Mascherbauer, Helmuth Haslacher, Guido Strunk, Martin Hülsmann, Noemi Pavo
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Oxford University Press 2021-06-01
Ráidu:	ESC Heart Failure
Fáttát:	Neprilysin Substance P Enkephalin ARNi Heart failure
Liŋkkat:	https://doi.org/10.1002/ehf2.13278
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!